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Dear Editor,
Shiffman’s1 editorial on global health networks is a useful 
addition to a relatively neglected area. The nature of global 
health networks is an important contributor to influence in the 
global health arena. However, in this editorial the necessarily 
brief overview of each of eight topics gives a limited picture 
and does not do justice to the many contextual differences 
which influence status in the global governance arena and, 
perhaps more importantly, the status and nature of the health 
networks themselves. 
It is certainly possible to draw a strong contrast between the 
Global Alcohol Policy Alliance (GAPA) and the Framework 
Convention Alliance, despite the comparable levels of harm 
experienced globally, and many reasons underpin this 
difference. One of the more influential has been the role of 
the industry. Since the widespread commercialisation of the 
production of both commodities the transnational alcohol 
corporations, learning from the adverse experience of 
tobacco, have done an excellent job of framing the problem 
definition to suit their ends (the contested framing mentioned 
by Shiffman1 is more between industry and public health 
networks rather than within or between them). They have 
succeeded in influencing sympathetic governments and this 
despite longstanding evidence of the industry’s subversion 
of alcohol research2,3 and effective alcohol policy (eg, Bakke 
and Endal4). Another important influence is a relative 
lack of informed advocates at national level and funding 
opportunities at both national and global level. This reflects 
the diffuse nature of alcohol related harm which makes a 
causal contribution to 60 diseases, and with much harm 
outside of the traditional health arena (for example impacts 
on productivity, violent crime and educational achievement); 
this has reduced the likelihood of support from any particular 
quarter, unlike the involvement of cancer and heart health 
charities in tobacco control. This relative lack of funding is 
one of the main factors inhibiting the development of the 
alcohol network.
Despite this, considerable progress has been made in recent 
years and it is not now accurate to characterise the GAPA 
network as consisting ‘predominantly of researchers from 
North American and European institutes’ (although these 
may have been the majority of interviewees in the 2011–2012 
research,5 on which Shiffman’s1 editorial is based). GAPA has 
active regional networks, particularly active in Africa which is 
one of the key foci for the transnational alcohol corporations 
at the present time. The 2015 biennial conference of the GAPA 
attracted participants from 60 countries, many from LMICs 
and funded by development agencies. In 2016 GAPA worked 
with several member states to ensure the challenges raised by 
the proliferation of alcohol marketing in the digital world was 
discussed in a Side Event at the World Health Assembly, and 
the need for a legally binding international health response 
was raised.
There is much to do and Shiffman’s analysis1 is useful in 
reinforcing the need to extend our focus on coalition building 
beyond the health sector and the need for transparency in our 
processes. The need to move beyond an ‘emerging network’ 
as GAPA, until recently, described itself on its website 
(http://globalgapa.org/) is urgent, given the ambitions of the 
transnational alcohol producers in the emerging economies of 
the world. Their expansion is assisted by the proliferation of 
economic agreements weakening national governments’ role 
in protecting their populations and the expansion of alcohol 
marketing in the global digital world. This is why GAPA has 
determined to advocate for a stronger response in the form 
of an international binding treaty to control alcohol supply, 
marketing and the role of the industry in alcohol policy 
development. 
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